This website uses cookies to enhance the user experience.
||
N

NEONATAL ANALYTICS AS931 763 954

Limited company
Gaustadalléen 21 0349 OSLO, Norge

NEONATAL ANALYTICS AS

Closed at November 11th, 2025, Voluntary liquidation
Forskning, utvikling, salg, leveranse og drift av screeningsystemer for sykdommer.

Organization

Chairman of the board
Operation time
2 years
- Aug 24, 2023 to Nov 11, 2025
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
30,000
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Annual total result 2024
35
NOK
Total equity 2024
30,039
NOK
Last update: Sep 17, 2025

Management

Board

NameRoleShares
Chairman-
Last update: Aug 24, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
I
INVEN2 AS
Ordinary shares
30,000
100 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2024: NOK 83,852,000
    Operating profit 2024: NOK -26,817,000
    Employees: 32

Financials

in NOK

Summary

Year20242023
Total operating income
0
4
Annual Total Result
35
4
Total assets
30,039
30,000
Total liabilities
0
0
Total equity
30,039
30,000

P&L

Year20242023
Total operating income
0
4
Total operating costs
0
0
Operating result
0
4
Financial income/costs
35
0
Profit before tax
35
4
Total tax & extraordinary income/cost
0
0
Annual Total Result
35
4

Balance overview

Year20242023
Total fixed assets
0
0
Total current assets
30,039
30,000
Total assets
30,039
30,000
Short term debt
0
0
Long term debt
0
0
Total liabilities
0
0
Contributed capital
30,000
30,000
Retained earnings
39
0
Total equity
30,039
30,000
Total equity and liabilities
30,039
30,000

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
1120
Public incorporated enterprises, owned by central government